Table 3.
Progress in health service coverage (2011–2015) and national coverage proportions in 2015
| Indicator | 2015 vs 2011 difference in weighted coverage proportions (%) (95% CI (%))* |
P value* | Weighted national coverage proportions (%), 2015 (95% CI (%)) |
HSDP† coverage target (%) for 2015 |
| Maternal and neonatal care | ||||
| ANC 4+ | 1.6 (±3.4) | 0.358 | 22.4 (±2.5) | 40 |
| Malaria prophylaxis | 8.6 (±3.9) | <0.001 | 33.1 (±2.9) | 40 |
| Tetanus prophylaxis | 3.1 (±3.1) | 0.047 | 13.7 (±2.3) | 80 |
| Institutional delivery | 10.5 (±3.4) | <0.001 | 27.0 (±2.6) | 25 |
| PNC for mother (any provider) | 1.7 (±3.6) | 0.359 | 22.8 (±2.6) | |
| Child immunisation | ||||
| Measles vaccination | 11.2 (±4.2) | <0.001 | 49.7 (±2.8) | |
| DPT3 vaccination | 13.1 (±3.6) | <0.001 | 34.7 (±2.6) | 85 |
| All basic vaccines | 11.3 (±3.0) | <0.001 | 20.8 (±2.3) | 50† |
| Childcare | ||||
| Vitamin A supplementation | −26.4 (±3.2) | <0.001 | 4.8 (±1.6) | 80 |
| Malaria treatment (ACT) | 15.8 (±3.6) | <0.001 | 31.3 (±2.8) | |
| Diarrhoea treatment (ORS) | 17.7 (±4.1) | <0.001 | 51.4 (±2.9) | 80 |
| Pneumonia care seeking | 5.9 (±4.0) | 0.004 | 66.1 (±2.8) | |
| HIV testing | ||||
| HIV testing, women | 7.3 (±2.8) | <0.001 | 17.0 (±2.2) | NA |
| HIV testing, men | 8.2 (±2.9) | <0.001 | 18.6 (±2.3) | NA |
| HIV-related knowledge | ||||
| MTCT knowledge, women | 6.0 (±2.9) | <0.001 | 17.3 (±2.4) | NA |
| MTCT knowledge, men | 6.6 (±3.4) | <0.001 | 23.1 (±2.7) | NA |
| HIV prevention knowledge, women | 0.5 (±1.9) | 0.641 | 8.9 (±1.6) | NA |
| HIV prevention knowledge, men | 1.9 (±3.0) | 0.218 | 17.6 (±2.3) | NA |
| HIV misconception knowledge 1 (mosquito), women | 7.0 (±4.0) | 0.001 | 38.5 (±2.9) | NA |
| HIV misconception knowledge 1 (mosquito), men | 6.9 (±4.0) | 0.001 | 48.8 (±2.8) | NA |
| HIV misconception knowledge 2 (food), women | 8.8 (±3.6) | <0.001 | 55.1 (±2.6) | NA |
| HIV misconception knowledge 2 (food), men | 7.1 (±3.7) | <0.001 | 64.0 (±2.6) | NA |
| HIV misconception knowledge 3 (witchcraft), women | 12.1 (±3.9) | <0.001 | 60.2 (±2.6) | NA |
| HIV misconception knowledge 3 (witchcraft), men | 6.8 (±3.7) | <0.001 | 68.1 (±2.5) | NA |
| STI-related knowledge | ||||
| STI knowledge, women | 9.4 (±3.8) | <0.001 | 48.6 (±2.8) | NA |
| STI knowledge, men | 12.0 (±4.0) | <0.001 | 58.1 (±2.9) | NA |
| HIV prevention and contraception | ||||
| Contraception (non-pregnant) | 0.6 (±2.6) | 0.653 | 7.1 (±1.9) | NA |
| Contraception (all married) | nc | 4.9 (±1.6) | 20 | |
| Condom use, women | nc | 18.0 (±9.1) | NA | |
| Condom use, men | nc | 38.2 (±6.7) | NA | |
*Results of two-sample, two-sided Z-test of proportions to test for significant change between 2011 and 2015.
†The HSDP target refers to card-confirmed vaccinations, while our indicators include mothers’ oral report of vaccinations.
ACT, artemisinin-based combination therapy; ANC, antenatal care; CI, Confidence Interval; DPT, diphtheria/pertussis/tetanus; HSDP, Health Sector Development Plan for the Republic of South Sudan; MTCT, mother-to-child transmission; NA, not applicable; nc, not computed comparative results, as explained above; ORS, oral rehydration salts; PNC, postnatal care; STI, sexually transmitted infection.